Congenital heart diseaseCohort study

Pulmonary Atresia With Intact Septum Survival, Reintervention, and Days in Hospital Through Childhood: Contemporary Outcomes From a National Registry

Circ Cardiovasc IntervPublished

  • national registry
  • linked to multiple national data sets
  • England and Wales
  • 2000-2022

Authors' conclusion

In a contemporary pulmonary atresia with intact ventricular septum cohort, transcatheter right ventricular decompression was the predominant initial intervention. This approach had lower in-hospital mortality compared with older multicenter series, with BiV repair achieved in more than half of the patients. Early mortality after nonantegrade flow augmentation remains high, likely due to nonmodifiable risk factors in severe cases. Long-term survival and hospital stay remain better for those amenable to BiV circulation, reflecting more favorable anatomy compared with those on the single-ventricle pathway, although reintervention is lower in the latter.

Study context

Population
Patients aged 0 to 18 years with pulmonary atresia with intact ventricular septum undergoing cardiac intervention
Participants
488 included patients
Exposure
Outcomes overall and by treatment pathway

Main finding

As reported in the abstract

Initial treatment pathway

right ventricular decompression as the first procedure

58.8%

of those, transcatheter

84.8%

stage 1 palliation

32.4%

died or were lost to follow-up before either intervention

8.8%

Observational data: associations, not effects.

Further findings

Outcomeright ventricular decompressionstage 1 palliation
1-year mortality by initial therapy7.7% (interval 4.5%–10.7%)37.2% (interval 29.0%–44.5%)

days

Median hospital stay — first year
35
Median hospital stay — annually by 10 years
2
  • Cardiac reintervention: after biventricular (BiV) repair 62.6% (interval 56.1%–68.4%)
  • Cardiac reintervention: after palliative stage 3 32.8% (interval 21.5%–44.4%)
  • Median hospital stay: functionally single-ventricle 52
  • Median hospital stay: BiV 28

Final pathway

achieved biventricular (BiV) repair
54.5%
functionally single-ventricle palliation
26.7%
noncommitted
18.8%

In-hospital mortality

Overall group in-hospital mortality
11.7%

Mortality · 1 and 5 years; median follow-up 8.9 years

1-year mortality
19.8% (95% CI, 16.2%-23.2%)
5-year mortality
20.8% (95% CI, 17.1%-24.4%)

Original publication

Pulmonary Atresia With Intact Septum Survival, Reintervention, and Days in Hospital Through Childhood: Contemporary Outcomes From a National Registry. Circ Cardiovasc Interv. Published 14 August 2026. doi:10.1161/circinterventions.125.016435

Summarised from the published abstract; every number is checked against it